Visitors
Company Overview
1. Company Overview and Development Background
1) Since 2008, Halcyon has served as the exclusive Korean supplier for Sound Oasis (USA), providing therapeutic sound products and related devices designed for sleep,
mental and physical relaxation, and pain management; the company specializes in "Acoustic-Vibration Technology."
2) Following five years of R&D starting in 2020, the company successfully developed the world’s first "Micro-Vibro Acoustic System Mattress" equipped with biosensors.
This product, developed in Korea using proprietary technology, is a "Vibro-Acoustic" device. It is the world's first to be registered as a medical device with the Korean Ministry of
Food and Drug Safety, featuring innovative capabilities for "continuous body pressure distribution" and "mental and physical relaxation."
Furthermore, as an outstanding "Sleep-Tech" product, it helps alleviate insomnia and prevent delirium in patients at risk of pressure ulcers.
3) The product's development was supported by over 1 billion KRW in funding from the Korean government; it has received numerous accolades including an award at the "Korea Invention & Patent Exhibition" and has secured approximately 30 domestic and international patents, certifications, and trademark registrations.
4) Through this exhibition, Halcyon aims to establish partnerships across various countries, regions, and distribution channels to facilitate its entry into the global market by 2027.
1) Since 2008, Halcyon has served as the exclusive Korean supplier for Sound Oasis (USA), providing therapeutic sound products and related devices designed for sleep,
mental and physical relaxation, and pain management; the company specializes in "Acoustic-Vibration Technology."
2) Following five years of R&D starting in 2020, the company successfully developed the world’s first "Micro-Vibro Acoustic System Mattress" equipped with biosensors.
This product, developed in Korea using proprietary technology, is a "Vibro-Acoustic" device. It is the world's first to be registered as a medical device with the Korean Ministry of
Food and Drug Safety, featuring innovative capabilities for "continuous body pressure distribution" and "mental and physical relaxation."
Furthermore, as an outstanding "Sleep-Tech" product, it helps alleviate insomnia and prevent delirium in patients at risk of pressure ulcers.
3) The product's development was supported by over 1 billion KRW in funding from the Korean government; it has received numerous accolades including an award at the "Korea Invention & Patent Exhibition" and has secured approximately 30 domestic and international patents, certifications, and trademark registrations.
4) Through this exhibition, Halcyon aims to establish partnerships across various countries, regions, and distribution channels to facilitate its entry into the global market by 2027.
